These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10945485)

  • 21. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
    Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
    Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non seminomatous germ cell tumors of the mediastinum treated successfully by the chemotherapy and surgical excision combination].
    Toumieux B; Lemarie E; Lavandier M
    Ann Chir; 1988; 42(2):162-6. PubMed ID: 2453136
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination chemotherapy with POMB/ACE (cisplatin, vincristine, methotrexate, bleomycin, actinomycin D, cyclophosphamide, etoposide) in advanced non-seminomatous testicular tumor].
    Masuda F; Kawahara M; Asano K; Shirakawa H
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1847-50. PubMed ID: 7574821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of advanced seminoma: retrospective study of 96 patients].
    Bompas E; Fléchon A; Biron P; Droz JP
    Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
    Otto T; Goepel M; Seeber S; Rübben H
    Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
    Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
    Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postchemotherapy surgery in nonseminomatous testicular tumors.
    Hornák M; Ondrus D; Matoska J; Cársky S
    Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ; Boyce H; Dunkel IJ; Diez B; Rosenblum M; Brualdi L; Finlay JL
    J Clin Oncol; 2004 Mar; 22(5):846-53. PubMed ID: 14990640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
    Matsuzaki J; Miyoshi Y; Miura T
    Hinyokika Kiyo; 2000 Dec; 46(12):879-86. PubMed ID: 11211804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
    Tanji S; Obara W; Sugimura J; Ohmori S; Matsushita Y; Tokunaga H; Konda R; Fujioka T; Murai K; Ishida Y
    Hinyokika Kiyo; 2004 Feb; 50(2):77-80. PubMed ID: 15101160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
    Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for non-seminomatous germ-cell tumours.
    Wilkinson PM
    J R Soc Med; 1985; 78 Suppl 6(Suppl 6):43-7. PubMed ID: 2582119
    [No Abstract]   [Full Text] [Related]  

  • 36. The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
    Ledermann JA; Holden L; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Brampton M
    Br J Urol; 1994 Aug; 74(2):225-30. PubMed ID: 7522874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
    Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
    Horwich A; Peckham MJ
    Cancer Treat Rep; 1986 Nov; 70(11):1329-31. PubMed ID: 2429765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.